ONIDA, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 15.871
NA - Nord America 9.571
AS - Asia 3.998
SA - Sud America 262
OC - Oceania 65
Continente sconosciuto - Info sul continente non disponibili 23
AF - Africa 11
Totale 29.801
Nazione #
US - Stati Uniti d'America 9.274
GB - Regno Unito 5.775
DE - Germania 4.959
CN - Cina 2.193
IT - Italia 1.394
SE - Svezia 978
UA - Ucraina 640
IN - India 441
IE - Irlanda 393
KR - Corea 378
FR - Francia 342
TR - Turchia 336
EU - Europa 307
RU - Federazione Russa 300
CA - Canada 280
FI - Finlandia 247
NL - Olanda 235
ES - Italia 189
SG - Singapore 187
CO - Colombia 167
DK - Danimarca 134
JP - Giappone 121
HK - Hong Kong 99
TW - Taiwan 62
BR - Brasile 61
BE - Belgio 59
AU - Australia 53
ID - Indonesia 49
CH - Svizzera 44
GR - Grecia 44
PL - Polonia 29
UZ - Uzbekistan 27
AT - Austria 22
IL - Israele 19
RO - Romania 17
PH - Filippine 16
NO - Norvegia 15
IR - Iran 14
AR - Argentina 13
NZ - Nuova Zelanda 12
PT - Portogallo 12
TH - Thailandia 11
VN - Vietnam 11
MX - Messico 9
SK - Slovacchia (Repubblica Slovacca) 9
MY - Malesia 8
BG - Bulgaria 7
CL - Cile 7
EG - Egitto 7
HU - Ungheria 6
PE - Perù 6
PK - Pakistan 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
HR - Croazia 4
BO - Bolivia 3
GT - Guatemala 3
KW - Kuwait 3
KZ - Kazakistan 3
LT - Lituania 3
AL - Albania 2
BD - Bangladesh 2
CY - Cipro 2
EC - Ecuador 2
GL - Groenlandia 2
LB - Libano 2
RS - Serbia 2
UY - Uruguay 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BY - Bielorussia 1
EE - Estonia 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
KY - Cayman, isole 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
SI - Slovenia 1
VE - Venezuela 1
Totale 30.086
Città #
Southend 5.263
Frankfurt am Main 3.714
Boise 1.203
Chandler 852
Seattle 696
Beijing 689
Jacksonville 617
Milan 469
Wilmington 466
Princeton 464
Ashburn 393
Dublin 385
Fairfield 299
Nanjing 253
Redmond 247
Woodbridge 203
Serra 191
Dearborn 185
Mountain View 184
Des Moines 170
Bengaluru 167
Ann Arbor 160
Andover 155
Sakarya 154
Houston 152
Munich 148
Bogotá 147
Redwood City 147
Boardman 146
Mcallen 112
Toronto 107
Jinan 103
Montréal 99
Cambridge 98
Somerville 98
Shanghai 95
Payette 93
Singapore 85
Nanchang 81
Shenyang 81
Berlin 80
New York 74
Garden Valley 72
Guangzhou 71
Hebei 67
Hong Kong 64
Jerome 56
Tianjin 56
Bitonto 53
Lewiston 53
Hangzhou 52
Orofino 51
Changsha 50
Helsinki 49
Phoenix 46
Margão 45
Cottonwood 42
Taipei 42
Eitensheim 41
Pisa 38
San Diego 38
Kunming 37
Saint Petersburg 37
Auburn Hills 34
Hefei 32
London 32
Rome 32
Tokyo 32
Brussels 31
Paris 31
Zhengzhou 30
Athens 29
The Dalles 29
Jiaxing 28
Los Angeles 28
Verona 27
Barcelona 26
Haikou 26
Kwai Chung 24
Grafing 23
Kiez 23
Madrid 22
Hyderabad 21
Ottawa 21
São Paulo 21
Falls Church 20
Turin 20
Fremont 19
Hamburg 19
Ningbo 19
Roxbury 18
Washington 18
Fuzhou 17
Hanover 17
Lanzhou 17
Nordman 16
Norwalk 16
San Jose 16
Nürnberg 15
Sydney 15
Totale 21.449
Nome #
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial 950
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome : A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial) 891
Acquired in-vitro resistance to STI571 (Imatinib mesylate) in BCR/ABL-positive cell lines: investigation of gene expression by molecular pathway microarrays 887
In-vitro effects of STI571 (Imatinib mesylate) in BCR/ABL-positive cell lines : modulation of gene expression assessed by pathway microarrays 873
An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies 575
Single institution retrospective analysis of bronchoalveolar lavage as etiological diagnostic tool for pulmonary infiltrates in patients with haematological malignancies 365
Autologous hematopoetic stem cell transplantation for refractory Crohn disease a randomized clinical trial 293
Upfront treatment of mantle cell lymphoma by sequential high dose immunochemotherapy supported by in vivo-purged stem cell double autologous transplantation : a single institution experience 290
Autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn's Disease : a review on behalf of ECCO and EBMT 288
RAS mutations vontribute to evolution of chronic myelomonocytic leukemia to the proliferative variant 270
Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution. 255
Long-term clinical and molecular outcomes following RIC-allogeneic HSCT from HLA-identical sibling in patients with advanced mycosis fungoides and Sézary syndrome 234
Allogeneic hematopoietic stem cell transplantation for MDS and CMML : recommendations from an international expert panel 234
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia 232
Immunomodulatory effects of unselected haematopoietic stem cells autotransplantation in refractory Crohn's disease 219
Activity of sphingosine kinase inhibitor in Chronic Myelogenous Leukemia cells sensitive and resistant to Imatinib Mesylate 215
TCRbeta Gene Rearrangements for Detection and Monitoring of Minimal Residual Disease after Allogenic Stem-Cell Transplantation in Patients with Advanced Mycosis Fungoides and Sézary Syndrome 208
Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease 201
Evolving pattern of microbial susceptibility to antibiotics in a HSCT unit 182
Autologous haematopoietic stem cell transplantation for refractory Crohn's disease : up to 2 year follow up with unselected stem cells 182
Autologous haematopoietic stem cell transplantation for refractory Crohn's disease : up to 2 year follow up without CD34+ cell selection 180
Indolent B-cell lymphomas treated upfront with antiviral therapy : a series of 13 patients 180
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) 174
Proposed diagnostic criteria for classical CMML, CMML variants and pre-CMML conditions 172
Impact of Cytogenetics on Outcome of Patients with MDS or Secondary AML Undergoing Allogeneic HSCT from HLA-identical Siblings : a Retrospective Analysis of the EBMT-CLWP 171
Evolution of empirical antifungal therapy in a bone marrow transplantation unit 169
Human bone marrow mesenchymal stem cells transplantation in 6-hydroxydopamine-lesioned rodents 166
Analisys of bone marrow hematopoietic and mesenchymal precursors in patients with amyotrophic lateral sclerosis 165
Sphingosine kinase 1 as a potential target to inhibit proliferation of myeloid leukemia cells 164
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome : a study from the Gruppo Italiano Trapianto di Midollo Osseo(GITMO) 163
Analysis of T-cell receptor rearrangements and microarrays in pediatric patients with cutaneous lymphoma 163
Array-based comparative genomic hybridization analysis of aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma (AECD8+L), extranodal NK/T nasal type lymphoma (ENK/T-NT) and blastic plasmocytoid dendritic cell neoplasia (BPDCN) 161
Autologous haematopoietic stem cell transplantation for Crohn's disease : a retrospective survey of long-term outcomes from the European Society for Blood and Marrow Transplantation 160
Evaluation of deoxycholate amphotericin-B toxicity after HSCT 157
Retrospective analysis of salvage regimen for relapsed or refractory classical Hodgkin lymphoma 157
Functional alteration of bone marrow mesenchymal stem cells of Amyotrophic Lateral Sclerosis Patients 156
Autologous stem cell transplantation in moderate-severe refractory Crohn’s disease : the Milan experience without CD34+ cells selection 155
Reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation in advanced mycosis fungoides and Sézary syndrome 154
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet 153
Autologous stem cell transplantation in Crohn's disease 151
Non-myeloablative allografting for newly diagnosed multiple myeloma : the experience of the Gruppo Italiano Trapianti di Midollo. 151
Evidence of graft-versus-leukaemia following allogeneic haematopoietic stem cell transplantation in patients with advanced mycosis fungoides and Sézary syndrome 150
Second malignancies in essential thrombocytosis: a retrospective analysis of 331 patients from a single institution (Abs. P351) 148
La formazione pre-laurea sulle cure palliative presso l'Università degli Studi di Milano 148
Bortezomib (Velcade®)-Thalidomide-Dexamethasone (VTD) versus Thalidomide-Dexamethasone to treat multiple myeloma (MM) patients progressing or relapsing after autologous transplantation : the MMVAR trial, a study from the myeloma subcommittee of the Chronic Leukemia Working Party of the EBMT 147
Autologous haematopoietic stem cell transplantation for refractory Crohn’s disease: updating the Milan experience without CD34+ cell selection 146
Comparison of Allogeneic Stem Cell Transplantation and Non-Transplant Approaches in Elderly Patients with Advanced Myelodysplastic Syndrome : Optimal Statistical Approaches and a Critical Appraisal of Clinical Results Using Non-Randomized Data 146
Autologous haematopoietic unselected peripheral blood stem cell transplantation in refractory Crohn's disease: up to 2-years follow-up of a phase I-II trial 145
Chronic myelomonocytic leukemia : identification of molecular abnormalities and monitoring of ras mutations-driven disease progression by allele-specific PCR 145
Immunomodulatory effects of autologous stem cell transplantation in refractory Cronh’s disease : updatring the Milan experience without CD34+ cell selection 144
Metalloproteinase alterations in the bone marrow of ALS patients 144
Amyotrophic Lateral Sclerosis Bone Marrow Characterization 143
Haploidentical Hematopoietic Stem Cell Transplant Complicated by Atypical Hemolytic Uremic Syndrome and Kidney Transplant from the Same Donor with No Immunosuppression but C5 Inhibition 143
Biological and molecular differences between the dysplastic and the proliferative variants of chronic myelomonocytic leukemia 142
Sphingolipids players in the leukemia arena 142
The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate 141
In vitro effect of second mitochondria-derived activator of caspases (SMAC) mimic compounds on myeloid leukemia cell lines 141
Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells : mechanistic studies of Smac mimetic 141
Autologous stem cell transplantation in moderate-severe refractory Crohn’s disease : the Milan experience without CD 34+ cells selection 139
Autologous hematopoietic stem cell transplantation : a successful treatment for early severe systemic sclerosis 139
A prospective phase II study on tandem autografting-nonmyeloablative allografting for newly diagnosed myeloma : final results of the Gruppo Italiano Trapianto Midollo Osseo 139
Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report 139
Unrelated mismatched cord blood transplantation in an adult with secondary AML 138
In vitro anti-leukaemia activity of sphingosine kinase inhibitor 138
Autologous non- myeloablative haematopoietic stem cell transplantation without CD34+selection for refractory Crohn's disease: the Milan experience after 5 years 138
Chronic myelomonocytic leukemia in younger patients : molecular and cytogenetic predictors of survival and treatment outcome 138
Autologous stem cell transplantation in moderate-severe refractory Crohn's disease : the Milan experience without CD34+ cells selection 137
Incidence and predictive factors of hepatic veno-occlusive disease after bone marrow transplantation 136
Isolation and characterization of L-NGFR(+) mesenchymal stem cells from adipose tissue and bone marrow: a comparison between the two sources 136
Pegylated G-CSF after autologous hematopoietic stem cell transplantation 135
Allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia with 17p Deletion: a retrospective EBMT analysis. 135
WHO Classification and WPSS Score Predict Post-Transplant Outcome in Adults with Myelodysplastic Syndrome : A Retrospective Study by GITMO - Gruppo Italiano Trapianto Midollo Osseo 135
Hyperleptinaemia in long-term transplant survivors with metabolic syndrome 135
High Frequency of Tumor Suppressor Genes Promoter Hypermethylation in Peripheral Blood of Patients with Myelodysplastic Syndromes 135
Bortezomib (Velcade)-thalidomide-dexamethasone (VTD) is superior to thalidomide-dexamethasone (TD) in patients with multiple myeloma (MM) progressing or relapsing after autologous transplantation 133
HLA-Identical Allogeneic Stem Cell Transplantation (alloSCT) for Patients with Primary Cutaneous T-Cell Lymphoma (CTCL): A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT-LWP) 132
Retrospective evaluation of amphotericin B deoxycholate toxicity in a single centre series of haematopoietic stem cell transplantation recipients 131
Acquired platelet dysfunction and overproduction of platelet cyclic AMP in two patients with myeloid malignancies 131
Autologous hematopoietic stem cell transplantation in early severe systemic sclerosis 130
Effect of Second Mitochondria-Derived Activator of Caspases (Smac) Mimetic Compounds on Leukemic Cell Lines 130
Second mitochondria-derived activator of caspases mimetic compounds (Smac) enhance tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) pro-Apoptotic effect on human myeloid leukemia cell lines 128
Unrelated mismatched cord blood transplantation in an adult patient with secondary AML 128
Biological characterization of hematopoietic and mesenchymal stem cell compartments in sporadic Amyotrophic Lateral Sclerosis 128
Mesenchymal stem cells fron bone marrow of patients with Systemic Sclerosis : properties and pathogenic perspectives 127
Analysis of risk factors for thrombotic events in 306 patients with essential thrombocythemia 126
Prognostic impact of pretransplantation transfusion-dependency and serum ferritin level in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation : a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 123
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation : A GITMO study 123
Acquisition of a RAS point mutation in a patients with chronic myelomonocytic leukemia after progression from dysplastic to proliferative variant 122
Synergistic in vitro effect of Second Mitochondria-derived Activator of Caspases mimetic compounds (Smac) and Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on human acute leukemia cell lines 122
Value of peripheral blood lymphocytes and MDAPS in CMML 121
Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion : a retrospective European Group for Blood and Marrow Transplantation analysis 121
A case of chronic mylomonocytic leukemia progressing from dysplastic to proliferative phenotype after acquisition of a RAS point mutation 121
Sphingosine kinase 1 is involved in proliferation and survival of chronic myeloid leukemia cells 121
Sphingosine Kinase 1 is involved in survival and proliferation of myeloid leukemia cells, representing a potential novel target for treatment 121
Life-threatening immune pancytopenia after MUD BMT for CML 121
Prognostic factors and scoring systems in chronic myelomonocytic leukemia : a retrospective analysis of 213 patients 120
Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status 120
Comparison between spontaneously occurring and post-transplant metabolic syndrome 119
Diagnosis and Management of Chronic Myelomonocytic Leukemia 118
Autologous stem cell transplantation for Crohn’s disease trial : early report of toxicity and efficacy 118
Totale 19.149
Categoria #
all - tutte 63.872
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.872


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019503 0 0 0 0 0 0 0 0 0 0 291 212
2019/20204.093 420 174 257 421 285 515 351 362 523 503 209 73
2020/20213.557 221 281 303 63 288 246 224 205 459 189 893 185
2021/20222.341 177 96 110 117 147 132 268 170 300 218 106 500
2022/20233.113 388 256 248 287 414 610 87 211 285 59 146 122
2023/20245.771 93 197 150 189 553 348 991 905 434 978 933 0
Totale 31.616